Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease?
暂无分享,去创建一个
G. Montalescot | P. Kamoun | B. Chadefaux-Vekemans | J. Bonnefont | A. Ankri | L. Thuillier | J. Aupetit | C. Rochette | J. Bonnefont | A. Kara | M. Couty
[1] K. Kawazoe,et al. Genetic polymorphism of 5,10‐methylenetetrahydrofolate increases risk of myocardial infarction and is correlated to elevated levels of homocysteine in the Japanese general population , 2000, Coronary artery disease.
[2] J. Wainscoat,et al. Factor V Leiden and Thermolabile Methylenetetrahydrofolate Reductase in Extreme Old Age , 1997, Thrombosis and Haemostasis.
[3] F. Costa,et al. The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis , 1997, Thrombosis and Haemostasis.
[4] Y. Yazaki,et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. , 1997, Circulation.
[5] KojiMaemura,et al. Genetic Polymorphism of 5,10-Methylenetetrahydrofolate Reductase (MTHFR) as a Risk Factor for Coronary Artery Disease , 1997 .
[6] S. Vasikaran,et al. Methylenetetrahydrofolate reductase gene and coronary artery disease. , 1997, Circulation.
[7] A. Marian,et al. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. , 1997, Atherosclerosis.
[8] J. Kastelein,et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. , 1997, Circulation.
[9] L. Taylor,et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. , 1996, Circulation.
[10] R. Banerjee,et al. Defects in human methionine synthase in cblG patients. , 1996, Human molecular genetics.
[11] M. Margaglione,et al. Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. , 1996, American journal of human genetics.
[12] K. Kario,et al. A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population , 1996, Japanese Journal of Human Genetics.
[13] N. Iwai,et al. Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. , 1996, Atherosclerosis.
[14] T. Goosen,et al. Molecular Genetic Analysis , 1996 .
[15] I. Rosenberg,et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.
[16] A. Motulsky. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. , 1996, American journal of human genetics.
[17] P. Frosst,et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. , 1996, American journal of human genetics.
[18] D C Shields,et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. , 1995, QJM : monthly journal of the Association of Physicians.
[19] H. Blom,et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? , 1995, The Lancet.
[20] R. D'Agostino,et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. , 1995, The New England journal of medicine.
[21] M. Stampfer,et al. Can lowering homocysteine levels reduce cardiovascular risk? , 1995, The New England journal of medicine.
[22] R. Matthews,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.
[23] H. Blom,et al. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. , 1995, American journal of human genetics.
[24] R. Matthews,et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification , 1994, Nature Genetics.
[25] H. Blom,et al. Treatment of mild hyperhomocysteinemia in vascular disease patients. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[26] J. Saudubray,et al. Methylenetetrahydrofolate reductase deficiency: Prenatal diagnosis and family studies , 1994, Prenatal diagnosis.
[27] P. Wong,et al. Thermolabile Defect of Methylenetetrahydrofolate Reductase in Coronary Artery Disease , 1993, Circulation.
[28] W. Willett,et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.
[29] J. Vallat,et al. Homocystinuria due to 5,10‐methylenetetra‐hydrofolate reductase deficiency revealed by stroke in adult siblings , 1991, Neurology.
[30] R. Clarke,et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.
[31] M. Norusis,et al. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. , 1991, American journal of human genetics.
[32] P. Wilson,et al. Plasma homocyst(e)ine levels in men with premature coronary artery disease. , 1990, Journal of the American College of Cardiology.
[33] P. Kamoun,et al. Rapid determination of total homocysteine in plasma. , 1989, Clinical chemistry.
[34] G. Boers,et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.
[35] P. Ueland,et al. Radioenzymic determination of homocysteine in plasma and urine. , 1985, Clinical chemistry.